Early Access — free while we kick the tires
EdgarHawk

Chou Kathryn K.

Director

Director
2 filings analyzed · 1 company · Latest 2025-12-12

Companies

Company Buys Sells Direction
IonQ, Inc. IONQ 0 4 Net selling

Activity

December 2025
2025-12-12 IonQ, Inc. IONQ
medium
Sell
20,000 shares
$1,027,980
Significance 5/10

Director Kathryn K. Chou sold 20,000 IONQ shares at $51.40; stock now $50.35, down -38.7% from 52-week high.

Director Kathryn K. Chou sold 20,000 shares on 2025-12-11 at $51.40, reducing her holdings by 24.7% from 80,839 to 60,839 shares. The transaction occurred while IONQ trades 38.7% below its 52-week high of $82.09, near the lower end of its 52-week range. Her prior IONQ sale on 2025-06-11 was followed by a 90-day return of +8.7%, indicating the stock rose substantially after that earlier insider sale—a poorly-timed outcome from an insider perspective. The company remains unprofitable with a negative annual net income of $-1.1B despite strong revenue growth of 95.4% year-over-year, presenting a contrasting fundamental picture between growth trajectory and profitability headwinds.

June 2025
2025-06-13 IonQ, Inc. IONQ
high
Sell
25,696 shares
$1,039,768
Significance 6/10

Director Chou sold 25,696 shares of IONQ at $40.46; still holds 62,115 shares post-sale

Kathryn K. Chou, a Director of IonQ, sold 25,696 shares at $40.46 on June 11, 2025, reducing her holdings by 29.3% from 87,811 to 62,115 shares. The company is unprofitable with net income of $-32,252,000.00 over its most recent full fiscal year, despite strong revenue growth of 95.4% year-over-year and a market cap of $9,376,111,974.24. The sale occurred at $40.46, compared to a current price of $37.84 and a 52-week range of $6.57–$51.07, placing the transaction near the middle of the company's trading range. This material reduction in a director's stake warrants investor attention given the company's unprofitable status and the size of the stake reduction.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access